Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Azizi

Showing results (31-40 of 267) with videos related to

Pageof 27
Sort By:
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 9, 2009
Managing cardiovascular and renal risk: the potential of direct renin inhibitionPeter S Sever, Alan H Gradman, Michel Azizi
La Revue Du Praticien|April 3, 2020
[What is resistant hypertension and how to diagnose it?]Aurélien Lorthioir, Inès Belmihoub, Laurence Amar, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 14, 2013
New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertensionMatthieu Monge, Aurélien Lorthioir, Guillaume Bobrie, et al.
Hypertension (Dallas, Tex. : 1979)|June 28, 2017
Detecting Nonadherence to Antihypertensive Treatment: Any Time, Anywhere?Idir Hamdidouche, Vincent Jullien, Stéphane Laurent, et al.
Hypertension (Dallas, Tex. : 1979)|March 17, 2004
Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humansMichel Azizi, Alvine Bissery, Maxime Lamarre-Cliche, et al.
Journal of Hypertension|February 10, 2006
Conformational changes in prorenin during renin inhibition in vitro and in vivoJoël Ménard, Than-Tam Guyene, Severine Peyrard, et al.
Hypertension (Dallas, Tex. : 1979)|July 10, 2013
Residual effect of renal denervation in patients with truly resistant hypertensionAlexandre Persu, Michel Azizi, Michel Burnier, et al.
Journal of Hypertension|January 16, 2002
Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney sizePatrick Rossignol, Gilles Chatellier, Michel Azizi, et al.
Current Hypertension Reports|January 8, 2016
Renal Denervation for Treatment of Hypertension: a Second Start and New ChallengesAlexandre Persu, Sverre Kjeldsen, Jan A Staessen, et al.
European Journal of Endocrinology|October 16, 2014
Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenomaLaurence Amar, Aurélien Lorthioir, Michel Azizi, et al.
Pageof 27

Showing results (31-40 of 267) with videos related to

Sort By:
Pageof 27
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 9, 2009
Managing cardiovascular and renal risk: the potential of direct renin inhibitionPeter S Sever, Alan H Gradman, Michel Azizi
La Revue Du Praticien|April 3, 2020
[What is resistant hypertension and how to diagnose it?]Aurélien Lorthioir, Inès Belmihoub, Laurence Amar, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 14, 2013
New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertensionMatthieu Monge, Aurélien Lorthioir, Guillaume Bobrie, et al.
Hypertension (Dallas, Tex. : 1979)|June 28, 2017
Detecting Nonadherence to Antihypertensive Treatment: Any Time, Anywhere?Idir Hamdidouche, Vincent Jullien, Stéphane Laurent, et al.
Hypertension (Dallas, Tex. : 1979)|March 17, 2004
Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humansMichel Azizi, Alvine Bissery, Maxime Lamarre-Cliche, et al.
Journal of Hypertension|February 10, 2006
Conformational changes in prorenin during renin inhibition in vitro and in vivoJoël Ménard, Than-Tam Guyene, Severine Peyrard, et al.
Hypertension (Dallas, Tex. : 1979)|July 10, 2013
Residual effect of renal denervation in patients with truly resistant hypertensionAlexandre Persu, Michel Azizi, Michel Burnier, et al.
Journal of Hypertension|January 16, 2002
Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney sizePatrick Rossignol, Gilles Chatellier, Michel Azizi, et al.
Current Hypertension Reports|January 8, 2016
Renal Denervation for Treatment of Hypertension: a Second Start and New ChallengesAlexandre Persu, Sverre Kjeldsen, Jan A Staessen, et al.
European Journal of Endocrinology|October 16, 2014
Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenomaLaurence Amar, Aurélien Lorthioir, Michel Azizi, et al.
Pageof 27